Trimetazidine Hydrochloride Multirelease tablets(Taizhou Overseas Pharma)

盐酸曲美他嗪多释片(越洋医药)

Report date: 2025/07/31 17:17:25

Base Information

Drug NameTrimetazidine Hydrochloride Multirelease tablets(Taizhou Overseas Pharma)
Drug Alias NameTrimetazidinaTrimetazidinumTrimetazidineCardiazidineVastarel +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetyl-CoA C-acyltransferase inhibitors
TargetsAcetyl-CoA C-acyltransferase
Therapy Area/IndicationsAngina, Stable
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAngina, Stable
Inactive IndicationsN/A

Other Information

ATC CodeN/A